Sources European Society of Cardiology, Obesity and Cardiovascular Disease: Clinical Consensus Statement European Medicines Agency, Wegovy (semaglutide) European Medicines Agency, Mounjaro (tirzepatide) European Medicines Agency, Ozempic (semaglutide) February 12, 2026 March 10, 2026 Start your weight loss journey with Yazen today Everything you need to do is to create an account and answer some questions about your health More articles Contraceptives and weight loss medications: How Wegovy and Mounjaro can affect the efficacy of birth control pills When treating with weight loss medications like Wegovy (semaglutide) and Mounjaro (tirzepatide), it is important to consider how the medications can affect fertility and the efficacy of contraceptives
Understanding what is changing requires moving beyond the drug itself and examining how its meaning shifts depending on why it is prescribed
CJC-1295 / Ipamorelin Peptide Therapy Information CJC-1295 and Ipamorelin remains to be one of the most effective peptide combinations for boosting your body's natural growth hormone production
A research review of clinical trials found that out of 407 patients, 0.2% reported a skin-burning sensation when taking 2.4 milligrams (mg) of semaglutide injections every week
Several DPP-4 inhibitors that can be taken orally as a tablet have been developed and are approved for clinical use